Description
Inluriyo (imlunestrant) is an oral selective estrogen receptor degrader (SERD) for estrogen receptor-positive breast cancer.
Oral SERD for breast cancer
Inluriyo (imlunestrant) is an oral selective estrogen receptor degrader (SERD) for estrogen receptor-positive breast cancer.
Reviews
There are no reviews yet.